Voss Capital, LP - 08 May 2025 SCHEDULE 13G Report for Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX)

Filing Manager
Voss Capital, LP
Reporting Manager
Voss Capital, LP
Security
Rein Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
RNTX
Shares outstanding
22,818,857 shares
Disclosed Ownership
1,277,856 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
14 May 2025, 20:26:02 UTC
Date of event
08 May 2025
Next filing
26 Sep 2025
SEC
View on sec.gov

Quoteable Key Fact

"Voss Capital, LP disclosed 5.6% ownership in Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX) on 08 May 2025."

Quick Takeaways

  • Voss Capital, LP filed SCHEDULE 13G for Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX).
  • Disclosed ownership: 5.6%.
  • Date of event: 08 May 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 May 2025, 20:26.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Voss Value Master Fund, LP 2.5% 583,206 583,206 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Value-Oriented Special Situations Fund, LP 1.4% 316,768 316,768 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Advisors GP, LLC 3.9% 899,974 899,974 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Voss Capital, LP 5.6% 1,277,856 1,277,856 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Cocke Travis W. 5.6% 1,277,856 1,277,856 0 /s/ Travis W. Cocke Travis W. Cocke